Cardiovascular Risk in Patients with HIV Infection
- 1 January 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 66 (15), 1971-1987
- https://doi.org/10.2165/00003495-200666150-00006
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- TipranavirDrugs, 2005
- Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatinAmerican Heart Journal, 2004
- Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjectsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people*HIV Medicine, 2004
- Prevalence of Hypertension in HIV-Positive Patients on Highly Active Retroviral Therapy (HAART) Compared with HAART-Na ve and HIV-Negative Controls: Results from a Norwegian Study of 721 PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Interactions Between Antiretroviral Drugs and Drugs Used for the Therapy of the Metabolic Complications Encountered During HIV InfectionClinical Pharmacokinetics, 2002
- Recreational drug misuse: issues for the cardiologistHeart, 2000
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976